DRAEGERWERK ST.A.O.N. news, videos and press releases
For more news please use our advanced search feature.
DRAEGERWERK ST.A.O.N. - More news...
DRAEGERWERK ST.A.O.N. - More news...
- EQS-News: Drägerwerk AG & Co. KGaA: Dräger makes sustainability and quality an Executive Board responsibility
- EQS-News: Drägerwerk AG & Co. KGaA: Dräger annual shareholders’ meeting approves significant dividend increase
- EQS-News: Drägerwerk AG & Co. KGaA: Dräger with solid business performance in the first quarter of 2024
- EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2024: Net sales and earnings below the strong prior-year quarter – Annual forecast confirmed
- EQS-News: Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and profit in fiscal year 2023 and pays significantly higher dividend
- EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures 2023: Net sales and earnings significantly above prior year – Dividend increase – Forecast 2024
- EQS-Adhoc: Drägerwerk AG & Co. KGaA: Annual forecast raised again
- EQS-Adhoc: Drägerwerk AG & Co. KGaA: Annual forecast raised again
- EQS-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052
- EQS-News: Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and earnings in the first nine months of 2023
- EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2023: Significant increase in earnings – full-year forecast raised
- EQS-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
- EQS-News: Drägerwerk AG & Co. KGaA: Dräger with significant increase in net sales and earnings in the first half of 2023
- EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures H1 2023: Net sales and earnings significantly above prior year – full-year guidance reaffirmed
- EQS-Adhoc: Drägerwerk AG & Co. KGaA: Correction of a prior-year figure in the ad-hoc notification dated April 17, 2023. All other content unchanged.
- EQS-News: Drägerwerk AG & Co. KGaA: Dräger's Annual General Meeting approves stable dividend for fiscal year 2022
- EQS-News: Drägerwerk AG & Co. KGaA: Dräger with strong net sales growth and positive earnings in the first quarter of 2023
- EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2023: Strong net sales growth and positive EBIT – forecast for 2023 confirmed
- EQS-News: Drägerwerk AG & Co. KGaA: Dräger expects return to profitable growth in 2023
- EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures 2022: net sales and earnings significantly below prior year despite continued high order backlog – forecast 2023: return to growth and profitability
- EQS-News: Drägerwerk AG & Co. KGaA: Dräger redeems last participation certificates – streamlining of capital structure completed
- EQS-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052
- EQS-News: Drägerwerk AG & Co. KGaA: Dräger expects faster sales recognition in the fourth quarter of 2022
- EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures for Q3 2022: net sales and earnings significantly below prior-year level despite continued high order backlog – annual targets no longer achievable
- EQS-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
- DGAP-News: Drägerwerk AG & Co. KGaA: Dräger expects significant recovery in business development in the second half of 2022
- DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures for H1 2022: net sales and earnings significantly below prior year despite strong order entry – guidance confirmed due to expected business recovery in H2
- DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures for the first quarter of 2022 - Increasing difficulties in the supply of electronic components make the lower end of the full-year guidance likely
- DGAP-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) and (3) of the Regulation (EU) No 596/2014 and Art. 2 (2) and (3) of the Delegated Regulation (EU) 2016/1052
- DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Net sales and earnings decline in 2022